Stay updated on Phase I Dose Escalation Clinical Trial S64315 with Venetoclax
Sign up to get notified when there's something new on the Phase I Dose Escalation Clinical Trial S64315 with Venetoclax page.

Latest updates to the Phase I Dose Escalation Clinical Trial S64315 with Venetoclax page
- Check4 days agoChange DetectedThe ClinicalTrials.gov site footer now identifies the platform as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check11 days agoChange DetectedThe footer’s ClinicalTrials.gov revision marker changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, replacing the prior v3.6.6. This indicates an update to the record metadata rather than substantive changes to the study content.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision entry, v3.6.6, was added to the record's history. The prior v3.6.5 entry was removed in this update.SummaryDifference0.1%

- Check74 days agoChange DetectedThe history now lists a new revision label v3.6.5, replacing the previous v3.6.4. This indicates a minor update to the page’s revision/version without altering study data or visible content.SummaryDifference0.1%

- Check88 days agoChange DetectedThe Study Record History now includes a new revision entry for v3.6.4, updating the history to reflect the latest change. This is a metadata update in the revision log and does not alter the study content.SummaryDifference0.1%

Stay in the know with updates to Phase I Dose Escalation Clinical Trial S64315 with Venetoclax
Enter your email address, and we'll notify you when there's something new on the Phase I Dose Escalation Clinical Trial S64315 with Venetoclax page.